Researchers aim to improve chemotherapy by enhancing drug efficacy and reducing heart toxicity through dual activation of CAR and Nrf2 pathways.

Exciting exhibition reaffirms the School’s commitment to scholarly inquiry across disciplines.

Leadership role provides oversight for grant and contract submissions and identification of funding sources and initiates collaborative and translational research programs.

Aziza Frank is a PhD candidate in the Department of Pharmaceutical Sciences.

Drs. Yan Shu and Fengtian Xue continue longtime collaboration, focusing on non-alcoholic steatohepatitis.